Novartis AG
https://www.novartis.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Novartis AG
CMO Eliav Barr On Merck & Co.'s Post-Keytruda Game Plan
Merck & Co. chief medical officer Eliav Barr talks with Scrip about the generational leadership change under way at the company, Merck's next oncology plays and its bold plan to rebuild a cardiovascular franchise.
UCB Makes Another Push To Get Bimzelx Over Finishing Line In US
The Belgian group was stunned by an FDA rejection in May for its dual IL-17A and IL-17F inhibitor and although the refiling is complete, UCB may still have to wait six months to get Bimzelx into the all-important US psoriasis market.
Teva's New CEO Francis Takes Over A Steadier – Though Still Rocky – Organization
Teva announced the appointment of former Sandoz CEO Richard Francis as its next leader as Kare Schultz steps down.
Growing Pains: Charting The Rapid Rise Of Chinese IO
Immuno-oncology therapies have revolutionized the treatment of many cancers over the last decade. This period has also witnessed a dramatic growth in China’s domestic pharmaceutical industry, and significant changes in the interaction between this industry and international pharma. This coalescence has led to excitement about the role that Chinese IO could play on the global stage, tempered by regulatory set-backs and revised marketing timelines.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Admune Therapeutics
- Amblyotech, Inc.
- Advanced Accelerator Applications SA (AAAP) (BioSynthema, Inc.)
- Aspen Japan K.K.
- Biocine
- CELLforCURE SASU
- Chiron Corporation
- CIBA-GEIGY
- Corthera Inc.
- CoStim Pharmaceuticals Inc.
- ESBATech AG
- Fougera Pharmaceuticals, Inc.
- Gyroscope Therapeutics Limited
- Hexal AG
- Lek Pharmaceuticals, Inc.
- Matrix Pharmaceuticals
- NeuTec Pharma
- Novartis Groupe France S.A.
- Novartis Pharmaceuticals
- Novartis Oncology
- Novogyne Pharmaceuticals (joint venture between Noven and Novartis)
- PowerVision, Inc.
- Protez Pharmaceuticals
- Sandoz Pharmaceuticals (Ever Neuro Pharma GmbH
- Ebewe Pharma)
- Selexys Pharmaceuticals Corporation
- Speedel Holding
- Spinifex Pharmaceuticals Pty. Ltd.
- Transcend Medical, Inc.
- Encore Vision, Inc.
- Ziarco Group Limited
- AveXis, Inc.
- BioLife Cell Bank, Inc.
- Endocyte, Inc.
- IFM Tre
- Zyma SA
- Annovation Biopharma, Inc.
- Boxford Subsidiary
- Curacyte Discovery GmbH
- Incline Therapeutics, Inc.
- ProFibrix B.V.
- Rempex Pharmaceuticals, Inc.
- Targanta Therapeutics Corporation
- Tenaxis Medical
- The Medicines Company
- Novartis Gene Therapies